OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment
Linlin Zhou, Danny Yu
Pharmacological Research (2024) Vol. 204, pp. 107205-107205
Open Access | Times Cited: 9
Linlin Zhou, Danny Yu
Pharmacological Research (2024) Vol. 204, pp. 107205-107205
Open Access | Times Cited: 9
Showing 9 citing articles:
Understanding the tumor microenvironment for personalized immunotherapy in early-onset head and neck squamous cell carcinoma
Yidan Shan, Di He, Feng-guo Yan, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Yidan Shan, Di He, Feng-guo Yan, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
ADAR1 Regulates Lipid Remodeling through MDM2 to Dictate Ferroptosis Sensitivity
Che-Pei Kung, Nick D. Terzich, Ma Xenia G. Ilagen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Che-Pei Kung, Nick D. Terzich, Ma Xenia G. Ilagen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives
Ibrahim S. Alalhareth, Saleh M. Alyami, Abdulrhman Alshareef, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 207-207
Open Access
Ibrahim S. Alalhareth, Saleh M. Alyami, Abdulrhman Alshareef, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 207-207
Open Access
Bio-Pathological Functions of Posttranslational Modifications of Histological Biomarkers in Breast Cancer
Anca-Narcisa Neagu, Claudiu-Laurentiu Josan, Taniya Jayaweera, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4156-4156
Open Access | Times Cited: 1
Anca-Narcisa Neagu, Claudiu-Laurentiu Josan, Taniya Jayaweera, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4156-4156
Open Access | Times Cited: 1
Acetylation of Steroidogenic Acute Regulatory Protein Sensitizes 17β-Estradiol Regulation in Hormone-Sensitive Breast Cancer Cells
Pulak R. Manna, Deborah Molehin, Ahsen U. Ahmed, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8732-8732
Open Access
Pulak R. Manna, Deborah Molehin, Ahsen U. Ahmed, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8732-8732
Open Access
Methylation modification of non-histone proteins in breast cancer: An emerging targeted therapeutic strategy
Mingyao Huang, Zirong Jiang, Y. Xu, et al.
Pharmacological Research (2024) Vol. 208, pp. 107354-107354
Open Access
Mingyao Huang, Zirong Jiang, Y. Xu, et al.
Pharmacological Research (2024) Vol. 208, pp. 107354-107354
Open Access
Stemness of Cancer: A Study of Triple-negative Breast Cancer From a Neuroscience Perspective
Mustafa B.A. Djamgoz
Stem Cell Reviews and Reports (2024)
Open Access
Mustafa B.A. Djamgoz
Stem Cell Reviews and Reports (2024)
Open Access
Nanoparticle‐Based drug delivery strategies for targeted therapy to hypoxic solid tumors
ZhouXue Wu, Junru Chen, Biqiong Wang, et al.
Chemical Engineering Journal (2024), pp. 158081-158081
Closed Access
ZhouXue Wu, Junru Chen, Biqiong Wang, et al.
Chemical Engineering Journal (2024), pp. 158081-158081
Closed Access
Proteomic profiling identifies feedback-activated signaling pathways that may limit chidamide efficacy in triple-negative breast cancer
Yanxia Zhang, Yunduo Liu, Bin Xiao, et al.
Asian Journal of Surgery (2024)
Open Access
Yanxia Zhang, Yunduo Liu, Bin Xiao, et al.
Asian Journal of Surgery (2024)
Open Access
Advancements in Clinical Research and Emerging Therapies for Triple-Negative Breast Cancer Treatment
Lili Xu, Pengtao Xu, Jingsong Wang, et al.
European Journal of Pharmacology (2024), pp. 177202-177202
Closed Access
Lili Xu, Pengtao Xu, Jingsong Wang, et al.
European Journal of Pharmacology (2024), pp. 177202-177202
Closed Access
Tumor microenvironment and immunotherapy for triple-negative breast cancer
Zijie Guo, Ziyu Zhu, Xixi Lin, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
Zijie Guo, Ziyu Zhu, Xixi Lin, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
